English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [5458]
News [12692]
Articles [177]
Editorials [5]
Conferences [249]
elearning [17]
Black patients with triple-negative breast cancer may be less likely to receive immunotherapy than white patients
Black patients with triple-negative breast cancer may be less likely to receive immunotherapy than white patients
Risk model identifies advanced cancer trial patients at highest risk for acute care use
Risk model identifies advanced cancer trial patients at highest risk for acute care use
Inflammatory cells in tumour microenvironment promote the transformation of prostate cancer cells into treatment-resistant cells
Inflammatory cells in tumour microenvironment promote the transformation of prostate cancer cells into treatment...
Clinical trial results show low-intensity therapy can achieve positive outcomes for certain paediatric leukaemia subtypes
Clinical trial results show low-intensity therapy can achieve positive outcomes for certain paediatric leukaemia...
New prostate biopsy technique lowers infection risk
New prostate biopsy technique lowers infection risk
New cancer cachexia treatment boosts weight gain and patient activity
New cancer cachexia treatment boosts weight gain and patient activity
Non-invasive method to predict survival in patients with liver cancer
Non-invasive method to predict survival in patients with liver cancer
Tailoring radiation therapy for brain cancer treatment: a personal investigation
Tailoring radiation therapy for brain cancer treatment: a personal investigation
Up to one-third of antibody drugs are nonspecific, study shows
Up to one-third of antibody drugs are nonspecific, study shows
FDA approves ribociclib with an aromatase inhibitor and ribociclib and letrozole co-pack for early high-risk breast cancer
FDA approves ribociclib with an aromatase inhibitor and ribociclib and letrozole co-pack for early high-risk...
<1...5051525354...1270>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top